Buy & Sell Kimberly Clark Corp (KMB) – Kimberly Clark Corp Price Today
Aura AI Summary
Key Stats
- $33.37BMarket Cap
- Consumer StaplesSector
- -7.39%3M Drawdown
- $39.91BEnterprise Value
- 5.09%Dividend Yield
- 1% Buy | 99% SellTrading Activity
- 84 daysTypical Hold Time
Kimberly Clark Corp (KMB) is currently valued at a market capitalization of $33.37B, with an enterprise value of $39.91B. Over the past 52 weeks, Kimberly Clark Corp has traded between a low of $93.05 and a high of $136.77, highlighting its annual price range. Over the past three months, Kimberly Clark Corp has recorded a drawdown of -7.39%, reflecting recent price volatility. Kimberly Clark Corp offers a dividend yield of 5.09%, with the most recent dividend of $1.28 paid on 05 Jun 26. On average, investors hold Kimberly Clark Corp for approximately 84 days, indicating typical investor behavior on the platform.
About Kimberly Clark Corp
With around half of sales from personal care and another third from tissue products, Kimberly-Clark sits as a leading manufacturer of tissue and hygiene realm. Its brand mix includes Huggies, Pull-Ups, Kotex, Depend, Kleenex, and Cottonelle. The firm also operates K-C Professional, which partners with businesses to provide safety and sanitary products for the workplace. Kimberly-Clark generates just over of half its sales in North America and more than 10% in Europe, with the rest primarily concentrated in Asia and Latin America.
Most Recent News
US government moves toward equity stakes in AI firms ahead of historic IPOs, reshaping investor ownership.
The US government is actively negotiating to take equity stakes in AI companies like OpenAI and Anthropic ahead of their planned IPOs, following a precedent set by its investment in Intel. This move aims to give the public a share in AI-driven growth...

Trulieve becomes first US cannabis stock listed on NYSE, signaling sector shift.
Trulieve Cannabis Corp. made history by becoming the first U.S. cannabis company to list on the New York Stock Exchange under the ticker TRLV. This milestone was enabled by the Trump administration's reclassification of cannabis to Schedule III for m...

BIO-key flagged by Nasdaq for late 10-Q filing, risking its Nasdaq listing status.
BIO-key International, a leader in biometric authentication, received a Nasdaq notice for failing to file its quarterly 10-Q report on time for Q1 2026. Nasdaq's notice indicates the company's compliance with listing rules is under review, and a hear...
